A large-scale analysis suggests that GLP-1 receptor agonists may do more than manage weight or blood sugar. New research suggests that GLP-1 weight loss drugs may provide lasting protection against heart attacks, strokes, and early death. Scientists at Anglia Ruskin University analyzed data from more than 90,000 patients across large international studies. They found that […]This is a curated summary.